Abridge Overview
Pro stress-test →Abridge transforms clinical conversations into documentation, insights, and actions for clinicians using generative AI. The company has raised $830 million since its founding in 2018 and earned the 2025 and 2026 Best in KLAS award, positioning itself as the leading ambient AI scribe for enterprise health systems.
Strategic Profile
Pro stress-test →Abridge unveiled the first AI-native clinician intelligence platform organized around the patient, built for clinicians, and designed to help health systems coordinate the clinical, financial, and evidence-based decisions that shape every moment of care. The company focuses primarily on ambient documentation and revenue cycle intelligence with deep Epic integration, but in June 2026 announced a Nvidia foundation model partnership and an Eli Lilly investment to expand beyond documentation into broader healthcare workflows.
Competitive Landscape
Pro stress-test →Nuance DAX Copilot is the closest enterprise competitor for large Epic health systems. Other competitors include Freed AI (focused on smaller practices) and specialty platforms like DeepCura and Heidi Health. Abridge maintains dominant position in enterprise ambient AI through unmatched Epic integration depth, KLAS market leader status, and the broadest health-system deployment footprint, though faces competition from EHR vendors and emerging full-workflow platforms.
Industry Context
Abridge operates in Clinical AI documentation platforms.
Key facts
Founded: 2018 · Headquarters: Pittsburgh, US